AVN 63.71 Increased By ▲ 0.02 (0.03%)
BOP 8.77 Decreased By ▼ -0.01 (-0.11%)
CHCC 134.55 Increased By ▲ 0.05 (0.04%)
DCL 10.01 Decreased By ▼ -0.04 (-0.4%)
DGKC 108.01 Increased By ▲ 0.01 (0.01%)
EFERT 64.27 Decreased By ▼ -0.18 (-0.28%)
EPCL 41.21 Decreased By ▼ -0.09 (-0.22%)
FCCL 21.00 No Change ▼ 0.00 (0%)
FFL 15.10 Increased By ▲ 0.05 (0.33%)
HASCOL 15.05 Decreased By ▼ -0.03 (-0.2%)
HBL 130.50 Decreased By ▼ -0.60 (-0.46%)
HUBC 81.75 Increased By ▲ 0.13 (0.16%)
HUMNL 7.35 Decreased By ▼ -0.05 (-0.68%)
JSCL 24.29 No Change ▼ 0.00 (0%)
KAPCO 28.49 Increased By ▲ 0.14 (0.49%)
KEL 3.70 Decreased By ▼ -0.01 (-0.27%)
LOTCHEM 11.72 Decreased By ▼ -0.03 (-0.26%)
MLCF 41.98 Increased By ▲ 0.13 (0.31%)
OGDC 93.20 Decreased By ▼ -0.13 (-0.14%)
PAEL 32.90 Decreased By ▼ -0.02 (-0.06%)
PIBTL 12.76 Decreased By ▼ -0.10 (-0.78%)
PIOC 95.00 No Change ▼ 0.00 (0%)
POWER 9.75 Decreased By ▼ -0.02 (-0.2%)
PPL 83.50 Decreased By ▼ -0.10 (-0.12%)
PSO 200.02 Increased By ▲ 0.02 (0.01%)
SNGP 56.52 Decreased By ▼ -0.08 (-0.14%)
STPL 13.15 No Change ▼ 0.00 (0%)
TRG 46.90 Increased By ▲ 0.30 (0.64%)
UNITY 23.05 Increased By ▲ 0.05 (0.22%)
WTL 1.04 Decreased By ▼ -0.01 (-0.95%)
BR100 4,133 Decreased By ▼ -155.2 (-3.62%)
BR30 21,019 Decreased By ▼ -858.48 (-3.92%)
KSE100 39,888 Decreased By ▼ -1298.86 (-3.15%)
KSE30 16,750 Decreased By ▼ -546.72 (-3.16%)
COVID-19 TOTAL DAILY
World

India declines proposal to test Sputnik-V COVID-19 vaccine in large study

  • India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works.
  • India is expected to overtake the United States over the next several weeks as the country with the world's largest number of cases.
08 Oct 2020

India's drug regulator has knocked back a proposal from Dr Reddy's Laboratories Ltd to conduct a large study in the country to evaluate Russia's Sputnik-V COVID-19 vaccine and has asked it to first test the vaccine in a smaller trial.

The recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from early-stage studies being conducted overseas is small, with no inputs available on Indian participants.

India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections.

India is expected to overtake the United States over the next several weeks as the country with the world's largest number of cases.

The Russian Direct Investment Fund (RDIF), which is marketing the Sputnik V, and Dr. Reddy's Laboratories last month announced their partnership to run clinical trials and distribute the vaccine in India.

Russia was the first country to grant regulatory approval for a novel coronavirus vaccine, and did so before large-scale trials were complete, stirring concerns among scientists and doctors about the safety and efficacy of the shot.

RDIF and Dr. Reddy's did not immediately reply to Reuters' requests for comment outside business hours.